Position in ATYR
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$98,637
+$67,030 QoQ
Shares Held
165,222
+307.7% QoQ
Ownership
0.168%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#23
of 90 holders
Holding Since
Mar 2020
24 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ATYR Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026RENAISSANCE TECHNOLOGIES LLC holds $3,952,593,796 across 312 Biotechnology names. ATYR ranks #273 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | EXEL |
Exelixis, Inc.
|
13,427,993 | $730,617,099 | |
| 2 | CORT |
Corcept Therapeutics Inc
|
5,261,628 | $457,498,554 | |
| 3 | INCY |
Incyte Corp
|
3,512,132 | $398,135,283 | |
| 4 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
320,008 | $158,957,573 | |
| 5 | JAZZ |
Jazz Pharmaceuticals plc
|
562,073 | $135,442,730 | |
| 6 | RPRX |
Royalty Pharma plc
|
1,935,800 | $108,540,306 | |
| 7 | TVTX |
Travere Therapeutics, Inc.
|
1,833,079 | $104,137,217 | |
| 8 | GMAB |
Genmab A/S
|
3,517,850 | $96,635,339 |
All Filings in ATYR
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $98,637 | 165,222 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $31,607 | 40,522 | Shares | Sole | 2026-05-14 | |
| 2025-06-30 | $2,628,059 | 518,355 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $1,449,464 | 479,955 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $2,079,527 | 574,455 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $2,022,548 | 1,149,175 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $2,018,349 | 1,293,814 | Shares | Sole | 2024-08-09 | |
| 2024-03-31 | $2,482,067 | 1,272,855 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $1,237,940 | 877,972 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $799,468 | 505,993 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $1,136,926 | 526,355 | Shares | Sole | 2023-08-11 | |
| 2023-03-31 | $331,075 | 157,655 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $363,706 | 166,076 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $562,575 | 187,525 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $426,834 | 150,825 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $593,074 | 110,855 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $949,847 | 127,155 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $1,631,267 | 179,655 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $860,124 | 176,255 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $1,076,722 | 241,960 | Shares | Sole | 2021-05-13 | |
| 2020-12-31 | $1,238,224 | 319,130 | Shares | Sole | 2021-02-10 | |
| 2020-09-30 | $1,319,228 | 408,430 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $1,624,285 | 365,830 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $585,200 | 209,000 | Shares | Sole | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||